Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: SEPTEMBER ISSUE PUBLISHED
  • SEPTEMBER 2021 Issue has been successfully launched on 1 September 2021.

Abstract

A STUDY ON THE EFFECTS OF SUVARNA PRASHANA IN THE MANAGEMENT OF TAMAKA SHWASA

*Dr. Rahul Vijay Chougule, Dr. Sumit R. Patil, Dr. Pramodini Chougule and Dr. Sangram R. Patil

ABSTRACT

Tamaka Shvasa is one among the five varieties of Shvasa explained in almost all the classics of Ayurveda, which is analogous with bronchial asthma mentioned in modern medicine. Since centuries Tamaka Shvasa remained to be a challenging and unremitting disease. There are several references of the Svarnaprashana in Ayurvedic literatures3 mentioning its actions like Balya, Brumhana, Rasayana, Medhya, Kantiprada, Tridoshahar, Vyadhidhvamsaka it is immunobooster so it is effective in tamaka shwasa. 30 shwasa patients selected for study of swarnaprashan for 1 month.

Keywords: Swrnaprashana, tamakashwasa, rasayana, vyadhidhvamsaka, tridoshahara.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More